ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,206, issued on Aug. 5, was assigned to Novartis AG (Basel, Switzerland).

"Heteroaryl butanoic acid derivatives" was invented by Birgit Bollbuck (Munich), Christian Markert (Riehen, Switzerland), Wolfgang Miltz (Allschwil, Switzerland) and Till Roehn (Zurich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention describes novel heteroaryl butanoic acid derivatives that are good drug candidates especially with regard to leukotriene A4 hydrolase (LTA4H). The present invention also relates to pharmaceutical compositions comprising said novel heteroaryl butanoic acid derivatives, methods of using said compounds in the treatment of various di...